isomethyleugenol has been researched along with Glioma in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (5.43) | 18.7374 |
1990's | 14 (10.85) | 18.2507 |
2000's | 10 (7.75) | 29.6817 |
2010's | 48 (37.21) | 24.3611 |
2020's | 50 (38.76) | 2.80 |
Authors | Studies |
---|---|
Brandner, S; Cheng, HY; Dawson, S; Faulkner, CL; Higgins, JPT; Jefferies, S; Kelly, C; Kurian, KM; McAleenan, A; Schmidt, L; Spiga, F; Wragg, C | 1 |
Chen, G; Huang, H; Luo, S; Tang, G; Wang, FF | 1 |
Chang, J; Wang, L; Xu, W; Yuan, J; Zhou, X | 1 |
Hölzl, D; Kral, M; Kraus, TFJ; Ladisich, B; Machegger, L; Pöppe, J; Schlicker, HU; Schwartz, C; Sotlar, K; Spendel, M; Zellinger, B | 1 |
Cheng, X; Gao, Y; Han, Z; Jin, H; Li, P; Liang, W; Lin, S; Liu, Z; Luan, Z; Qian, R | 1 |
McDonald, KL; Noor, H; Whittaker, S | 1 |
Cao, H; Chao, M; Chen, F; Wang, L; Xie, X | 1 |
Chu, Q; Lou, Y; Lv, P; Mao, M; Wang, LJ | 1 |
Dong, W; Liu, L; Liu, X; Ruan, X; Shao, L; Wang, D; Wang, P; Xue, Y; Yang, C; Zhang, M | 1 |
Jiang, J; Wang, S; Xu, Z | 1 |
Feng, N; Wei, Y; Wu, B; Xiang, Z; Zhang, W; Zhang, X; Zhao, B | 1 |
Ebrahimi, A; Herrlinger, U; Kaluza, L; Pietsch, T; Waha, A | 1 |
Bao, Y; Li, H; Ma, C; Xiao, B; Xu, J | 1 |
Booth, TC; Salihoğlu, AK | 1 |
Hu, X; Liu, H; Liu, L; Luo, T; Wang, J; Zhang, C; Zhen, Z; Zheng, Y | 1 |
Ajuyah, P; Barahona, P; Chambers, H; Cowley, MJ; D'Arcy, C; Ekert, PG; Gifford, AJ; Haber, M; Hansford, JR; Khuong-Quang, DA; Lau, LMS; Manoharan, N; Mayoh, C; Nicholls, W; Senapati, A; Tyrrell, V; Valdes-Mora, F; Williams, MM; Wong, M; Wood, PJ; Ziegler, DS | 1 |
Guowei, L; Qianqian, X; Xiufang, L; Yanping, J | 1 |
Baihetiyaer, Y; Feng, Z; Jiang, L; Kasimu, M; Liu, Y; Maimaiti, A; Pei, Y; Turhon, M; Wang, X; Wang, Y; Wang, Z; Xie, Z | 1 |
Bruce, JN; Canoll, PD; Cheng, SK; Grinband, J; Iwamoto, FM; Kachnic, LA; Kinslow, CJ; Kumar, P; McKhann, GM; Mercurio, A; Rae, AI; Siegelin, MD; Sisti, MB; Taparra, K; Upadhyayula, PS; Wang, TJC; Yu, JB | 1 |
Ferrer, VP; Machado, GC | 1 |
Bruce, JN; Canoll, PD; Cheng, SK; Gill, BJA; Grinband, J; Horowitz, DP; Iwamoto, FM; Kachnic, LA; Kinslow, CJ; Kumar, P; McKhann, GM; Neugut, AI; Rae, AI; Siegelin, MD; Sisti, MB; Taparra, K; Wang, TJC; Yu, JB | 1 |
Li, N; Li, X; Li, Y; Li, Z; Shen, L | 1 |
Chen, J; Chen, X; Chen, Y; Cheng, Z; Duan, H; Huang, Y; Li, K; Li, Q; Li, Y; Lin, X; Liu, J; Lu, Y; Pan, G; Qin, Z; Shen, X; Shu, M; Wang, F; Wang, G; Wang, X; Xing, F; Yang, S; Zeng, Y; Zhang, H; Zhang, Y | 1 |
Li, J; Liang, C; Liu, Q; Liu, Y; Xiao, Z; Yan, X; Zhang, Y | 1 |
Chen, J; Huang, X; Jiang, J; Li, X; Li, Z; Liu, R; Long, S; Wang, L; Wei, W; Xu, H; Xu, Z; Yan, Y; Zhou, Q | 1 |
Chen, R; Chen, X; Gimple, RC; Jiang, T; Lin, P; Liu, L; Liu, Q; Liu, X; Liu, Z; Luo, J; Prager, BC; Rich, JN; Wang, D; Wu, E; Wu, Q; Wu, W; Xie, Q; Yu, J; Zhang, W; Zhang, Y; Zhao, W | 1 |
Andrade, J; Garcia, BA; Granat, J; Jin, Y; Lee, CH; LeRoy, G; Lund, P; Reinberg, D; Saldaña-Meyer, R; Stafford, JM; Ueberheide, B; Yu, JR | 1 |
Chen, Y; Ge, J; Wang, X; Wu, B; Zhong, S | 1 |
Li, F; Zhang, C; Zhang, G | 1 |
Chen, W; Feng, F; Feng, S; Jiang, C; Kong, Z; Liu, S; Lyu, Y; Ma, W; Wang, R; Wang, Y; You, H; Zhang, Y; Zhao, D; Zhu, R | 1 |
Chen, Y; Deng, Y; Lodhi, AF; Ma, H; Sun, C; Sun, F; Wang, H; Yan, L; Zhang, P | 1 |
Cao, X; Du, F; Gao, Y; Guo, Y; Li, PA; Lv, Y; Wang, F; Wang, S; Wu, Y; Yu, J | 1 |
Hatanaka, KC; Hida, K; Ishi, Y; Ishida, Y; Oda, Y; Seki, T; Takamiya, S; Tanaka, S; Yamaguchi, S; Yamazaki, K | 1 |
Hao, L; Li, M; Liu, L; Ma, L; Song, S; Wang, G; Wang, L; Yu, C; Zhang, Z | 1 |
Alkam, D; Day, JD; De Loose, A; Ho, SM; Jenjaroenpun, P; Leung, YK; Nookaew, I; Rodriguez, A; Ussery, DW; Wongsurawat, T | 1 |
Cahill, DP; Miller, JJ | 1 |
Allis, CD; Deshmukh, S; Garcia, BA; Jabado, N; Jain, SU; Juretic, N; Khazaei, S; Lewis, PW; Lu, C; Lundgren, SM; Marchione, DM; Wang, X; Weinberg, DN | 1 |
Cheng, H; Dai, X; Hu, Y; Wang, H; Wang, J; Wu, B; Ye, L | 1 |
Bareke, E; Chen, H; Coradin, M; Garcia, BA; Harutyunyan, AS; Horth, C; Jabado, N; Krug, B; Lu, T; Majewski, J; Marchione, DM; Nikbakht, H; Russo, C | 1 |
Cai, H; Chen, F; Chen, Z; Hu, Y; Li, C; Ni, X; Wang, J; Xi, S; Yu, Y | 1 |
Agnihotri, S; Bridge, T; Hawkins, C; Huang, A; Kim, B; Li, C; Milos, S; Pajovic, S; Patel, P; Phillips, L; Rakopoulos, P; Ryall, S; Sheth, J; Siddaway, R; Srikanthan, D; Yu, M | 1 |
Bartom, E; Huang, TY; Morgan, M; Piunti, A; Qi, J; Saratsis, AM; Shilatifard, A | 1 |
Chen, N; Gong, Q; Su, X; Sun, H; Tan, Q; Wan, X; Wang, W; Yang, X; Yue, Q; Zhang, S | 1 |
Li, X; Meng, Y | 1 |
Guo, L; He, W; Hua, J; Li, X; Liao, S; Liu, X; Wang, W; Wu, Y; Xiao, X; Xu, Y; Zhou, J | 1 |
Huang, J; Liu, J; Qiu, O; Qu, S; Wang, H | 1 |
Navarria, P; Pessina, F; Politi, LS; Simonelli, M | 1 |
Chen, J; Du, J; Huang, X; Huang, Z; Lan, W; Lin, Q; Lin, W; Ma, W; Shen, Y; Yao, X; Zhang, N; Zheng, B | 1 |
Horbinski, C; McCortney, K; Stupp, R | 1 |
Jiang, X; Qiu, Y; Wang, M; Wang, X; Wu, Z; Yu, H; Zheng, J; Zhou, Z | 1 |
Chen, SH; Cui, WY; Lv, QL; Shen, XL; Tan, ZL; Wang, LC; Zhang, Z | 1 |
Li, L; Pan, T; Sun, C; Wu, F; Wu, S; Xia, L; Zhang, P; Zhou, F | 1 |
Anderson, J; Cantilena, S; de Boer, J; Hargrave, D; Meier, S; Michod, D; Niklison Chirou, MV; Salomoni, P | 1 |
Guan, S; He, Y; Su, Y; Zhou, L | 1 |
Carman, C; Gursoy-Yuzugullu, O; Myronakis, M; Price, BD; Serafim, RB; Valente, V | 1 |
Akagi, Y; Hata, N; Hatae, R; Hideki, M; Hiwatashi, A; Iihara, K; Iwaki, T; Kuga, D; Mizoguchi, M; Sangatsuda, Y; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K | 1 |
Aguiar, RCT; Dahia, PLM; Elkashef, SM; Jiang, D; Lin, AP; Myers, J; Sill, H | 1 |
Ding, Y; Dong, MQ; Geng, Q; Li, J; Li, X; Nai, S; Su, XD; Xu, X; Yu, K; Zhu, B; Zhu, WG | 1 |
Dai, B; Guan, F; Hu, Z; Huang, H; Mao, B; Su, H; Xiao, Z; Zhu, G | 1 |
Cai, J; Dinislam, M; Duan, C; Gao, F; Gao, W; Han, B; Jiang, C; Kang, C; Lin, L; Meng, X; Wang, R; Wu, P | 1 |
Deng, J; Jiao, X; Li, J; Qiu, D; Sun, Z; Wan, X; Xia, Z; Yang, R | 1 |
Bender, B; Bier, G; Brendle, C; Castaneda Vega, S; Ernemann, U; Hempel, JM; Klose, U; Schittenhelm, J; Skardelly, M; Tabatabai, G | 1 |
Marosi, C | 1 |
Arnold, EP; Haile, S; Hulleman, E; Kadapakkam, M; Labanieh, L; Mackall, CL; Majzner, RG; Monje, M; Mount, CW; Rietberg, SP; Sundaresh, S; Vogel, H; Woo, PJ | 1 |
Chang, JF; Chen, L; He, ZM; Jiang, CZ; Jing, YY; Kang, X; Liu, KN; Mao, ZY; Shen, Y; Sun, FL; Sun, J; Tang, HY; Wang, C; Wang, DL; Wei, HM; Wu, JY; Xu, RG; Yang, XM; Zeng, SY; Zhang, Y; Zhu, RB | 1 |
Cheng, L; Daniels, DJ; Fang, D; Gan, H; Lee, JH; Sarkaria, JN; Zhang, Z; Zhou, H | 1 |
Choi, SH; Chun, SJ; Kim, IH; Kim, JW; Kim, TM; Lee, ST; Park, CK; Park, SH | 1 |
Fang, J; Gu, L; Huang, Y; Li, GM; Li, H; Mao, G; Rennert, G; Yang, S | 1 |
Chen, H; Dong, Z; Liu, M; Liu, Y; Ma, C; Wang, Y; Wu, R; Yan, Y; Yang, L | 1 |
Chen, W; Chen, Y; Deng, X; Lian, M; Long, H; Qian, D; Shi, P; Wang, H; Wang, K; Xiao, D | 1 |
Delaney, K; Pankowski, A; Steiner, FA; Strobino, M; Wenda, JM | 1 |
Albrecht, S; Bognar, L; Busche, S; Faury, D; Fleming, A; Fontebasso, AM; Garami, M; Gerges, N; Hadjadj, D; Hauser, P; Jabado, N; Jones, DT; Khuong-Quang, DA; Klekner, A; Kool, M; Korshunov, A; Lepage, P; Liberski, PP; Liu, XY; Majewski, J; Montpetit, A; Pfister, SM; Schwartzentruber, J; Staffa, A; Sturm, D; Witt, H; Zadeh, G; Zakrzewska, M; Zakrzewski, K | 1 |
Biller, SA; Brennan, CW; Campos, C; Chan, TA; Chen, Y; Clark, O; Graeber, TG; Grommes, C; Kernytsky, A; Komisopoulou, E; Kunii, K; Liu, W; Mellinghoff, IK; Miller, A; Oldrini, B; Palaskas, N; Pedraza, A; Popovici-Muller, J; Rohle, D; Rosenblum, MK; Schalm, S; Silverman, L; Su, SM; Tsoi, J; Turcan, S; Wang, F; Yang, H; Yen, KE | 1 |
Chan, KM; Fang, D; Gan, H; Gupta, N; Hashizume, R; James, CD; Jenkins, R; Mueller, S; Sarkaria, J; Schroeder, M; Yu, C; Zhang, Z | 1 |
Collins, VP; Harris, FP; Jefferies, SJ; Price, SJ; Watts, C | 1 |
Byun, HS; Choi, SW; Hong, JH; Huang, SM; Hur, GM; Jeon, J; Kim, JM; Kim, SH; Lee, JH; Lee, Y; Li, Y; Liu, ZG; Lu, T; Park, J; Park, KA; Ro, H; Shen, HM; Sohn, KC; Stark, GR; Zhang, T | 1 |
Arita, H; Fukushima, S; Ichimura, K; Matsushita, Y; Miyakita, Y; Narita, Y; Ohno, M; Shibui, S; Takami, H; Yoshida, A | 1 |
Feng, D; Hu, Q; Li, H; Ma, H; Su, Y; Tao, H; Wang, X; Zhang, C | 1 |
Eissenberg, JC; Florens, L; Gao, X; Herz, HM; Jackson, J; Morgan, M; Rickels, R; Shilatifard, A; Swanson, SK; Washburn, MP | 1 |
Chapet, S; Lévy, S; Mazeron, JJ | 1 |
Andor, N; Chen, X; Fang, D; Gan, H; Gupta, N; Hashizume, R; Huang, X; Ihara, Y; James, CD; Lerner, R; Mueller, S; Ngo, V; Paris, PL; Petritsch, C; Solomon, D; Tom, MW; Waldman, TA; Zhang, Z | 1 |
He, W; Liu, R; Yang, SH; Yuan, F | 1 |
Filatov, MV; Kovalev, RA; Semenova, EV; Shtam, TA; Volnitskiĭ, AV | 1 |
Cui, H; Matthiesen, R; Mu, Y; Su, X; Sun, W; Xi, YG; Yu, L | 1 |
Alyami, W; Bouhlel, A; Li, A; McConathy, J; Rich, K; Yuan, L | 1 |
Bjerkvig, R; Johannessen, TA; Mukherjee, J; Ohba, S; Pieper, RO; Ronen, SM; Viswanath, P | 1 |
Balvers, RK; Dirven, CM; Lamfers, ML; Leenstra, S | 1 |
Allis, CD; Lu, C; Weinberg, DN | 1 |
Abshiru, NA; Bartom, ET; Hashizume, R; Horbinski, CM; James, CD; Kelleher, NL; Lulla, RR; Ma, Q; Marshall, SA; Misharin, AV; Morgan, MA; Piunti, A; Rendleman, EJ; Saratsis, AM; Shilatifard, A; Takahashi, YH; Woodfin, AR | 1 |
Gurley, S; Krishnamurthy, M; Moore, BM | 1 |
Chen, T; Gao, J; Gong, Y; Guo, X; Hu, G; Liu, J; Liu, W; Peng, X; Qiang, B; Yin, B; Yuan, J; Zhao, J | 1 |
Cerdán, S; López-Larrubia, P; Rodrigues, TB | 1 |
Chen, Y; Hu, C; Shen, L; Wang, H; Wang, S; Wang, Z; Yue, W; Zhang, X; Zhou, J | 1 |
Catapano, G; D'Urso, OF; D'Urso, PI; Gianfreda, CD; Marsigliante, S; Montinaro, A; Muscella, A; Storelli, C | 1 |
Hartmann, C; Korshunov, A; von Deimling, A | 1 |
Fukushima, T; Katayama, Y; Nagase, H; Ohta, T; Shinojima, Y; Terui, T; Watanabe, T; Yachi, K; Yoshino, A | 2 |
Abdel-Wahab, O; Berger, SL; Chan, TA; Edwards, CR; Figueroa, ME; Kapoor, GS; Khanin, R; Levine, RL; Lu, C; Mellinghoff, IK; Melnick, A; O'Rourke, DM; Rohle, D; Thompson, CB; Turcan, S; Ward, PS; Wellen, KE | 1 |
Peng, X; Qiang, B; Tan, X; Wang, S; Yang, B; Yin, B; Yuan, J | 1 |
Geng, J; Luo, H; Pu, Y; Wu, X; Xu, W; Yang, Z; Zhou, Z | 1 |
Adamopoulos, C; Papavassiliou, AG; Piperi, C; Spyropoulou, A | 1 |
Laird, PW; Marczinek, K; Nürnberg, P; Rohde, K; Szymas, J; Thiel, G; Uhlmann, K; Vogel, S; Zeller, C | 1 |
Godfraind, C; Rousseau, E; Ruchoux, MM; Scaravilli, F; Vikkula, M | 1 |
Itaba, N; Kamitani, H; Maegawa, S; Nanba, E; Oshimura, M; Otsuka, S; Tahimic, CG; Watanabe, T | 1 |
Gao, Y; Guan, M; Liu, W; Lu, Y; Su, B; Xu, M | 1 |
Desrosiers, RR; Lanthier, J; Lapointe, M; Moumdjian, R; Régina, A | 1 |
Makrigiorgos, GM; Price, BD; Roy, K; Wang, L | 1 |
du Plessis, DG; Dunn, JR; Gee, AL; Moss, DJ; Reed, JE; Reeves, P; Sellar, GC; Shaw, EJ; Walker, C; Warnke, PC | 1 |
Cheah, MS; Hoffman, RM; Wallace, CD | 1 |
Koschel, K; Münzel, P | 1 |
Costello, JF; Futscher, BW; Kroes, RA; Pieper, RO | 1 |
Baylin, SB; Burger, PC; Gabrielson, E; Herman, JG; Lee, DJ; Mao, L; Merlo, A; Sidransky, D | 1 |
Berger, MS; Blank, A; Bobola, MS; Silber, JR | 1 |
Braun, PE; Cox, ME; Gao, EN | 1 |
Costello, JF; Futscher, BW; Graunke, DM; Pieper, RO; Tano, K | 1 |
Chiba, M; Gasa, S; Hashi, K; Ibayashi, Y; Suetake, K; Taki, T; Yamaki, T | 1 |
Berger, MS; Cavenee, WK; Costello, JF; Huang, HS | 1 |
Baylin, SB; Herman, JG; Jen, J; Merlo, A | 1 |
Aoki, Y; Kayama, T; Komura, J; Nakura, H; Nata, M; Ono, T; Sagisaka, K; Sakurai, H; Sasano, H; Tawa, R; Uyeno, S; Yoshimoto, T | 1 |
Costello, JF; Futscher, BW; Patel, S; Pieper, RO; Ting, SA | 1 |
Endo, S; Feng, X; Ichikawa, T; Koga, H; Kumanishi, T; Onda, K; Washiyama, K; Zhang, S | 1 |
Bruner, JM; Fueyo, J; Gomez-Manzano, C; Kyritsis, AP; Levin, VA; Saito, Y; Yung, WK; Zhang, B; Zhang, W | 1 |
de Graaf, RA; Garwood, M; Gruetter, R; Luo, Y; Rydzewski, J; Schleich, T | 1 |
Akira, S; Hirano, T; Isshiki, H; Kishimoto, T; Nakajima, T; Shimamoto, T; Tanabe, O | 1 |
Brophy, PJ; Gillespie, CS; McKenzie, RC | 1 |
Aida, T; Bodell, WJ | 1 |
Perria, L; Viale, GL | 1 |
Viale, GL | 1 |
Grosso, G; Kroh, H; Viale, E; Viale, GL | 1 |
14 review(s) available for isomethyleugenol and Glioma
Article | Year |
---|---|
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Glioma; Humans; Methylation; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins | 2021 |
Diagnostic performance of radiomics using machine learning algorithms to predict MGMT promoter methylation status in glioma patients: a meta-analysis.
Topics: Brain Neoplasms; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Machine Learning; Methylation; Tumor Suppressor Proteins | 2021 |
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature.
Topics: Astrocytoma; Biology; Brain Neoplasms; Chromosomes, Human, Pair 1; DNA; Glioblastoma; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mutation; Oligodendroglioma | 2022 |
The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.
Topics: Adenosine; Glioblastoma; Glioma; Humans; Methylation; RNA; Tumor Microenvironment | 2022 |
The Critical Role of RNA m
Topics: Apoptosis; Glioma; Humans; Methylation; MicroRNAs; RNA, Messenger; Tumor Microenvironment | 2023 |
Insights into the regulatory role of RNA methylation modifications in glioma.
Topics: 5-Methylcytosine; Glioma; Humans; Methylation; RNA; Transcriptome | 2023 |
The role m
Topics: Adenosine; Animals; Central Nervous System; Glioma; Humans; Methylation; Models, Biological; RNA | 2021 |
[Management of gliomas].
Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Chemoradiotherapy; Chromosome Deletion; Chromosomes, Human, Pair 1; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Dose Fractionation, Radiation; Drug Resistance, Neoplasm; Glioma; Humans; Lomustine; Methylation; Multicenter Studies as Topic; Neoplasm Proteins; Neurosurgical Procedures; O(6)-Methylguanine-DNA Methyltransferase; Procarbazine; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Temozolomide; Treatment Outcome; Vincristine | 2014 |
Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells.
Topics: Biopsy; Cell Culture Techniques; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Methylation; Neoplastic Stem Cells; Tumor Cells, Cultured | 2017 |
Oncogenic Mechanisms of Histone H3 Mutations.
Topics: Carcinogenesis; Chromatin; Glioma; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Mutation, Missense; Protein Processing, Post-Translational | 2017 |
The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations.
Topics: Biomarkers, Tumor; Brain Neoplasms; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mutation; Proto-Oncogene Proteins B-raf; Tumor Suppressor Proteins | 2011 |
Non-promoter hypermethylation of zygote arrest 1 (ZAR1) in human brain tumors.
Topics: Adenoma; Biomarkers, Tumor; Brain Neoplasms; Egg Proteins; Glioma; Humans; Methylation; Oligonucleotide Array Sequence Analysis; Oocytes; Pituitary Neoplasms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Zygote | 2011 |
Deregulated chromatin remodeling in the pathobiology of brain tumors.
Topics: Acetylation; Adenosine Triphosphate; Antineoplastic Agents; Brain Neoplasms; Chromatin Assembly and Disassembly; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioma; Histone Deacetylase Inhibitors; Histones; Humans; Macromolecular Substances; Methylation; Molecular Targeted Therapy; Neoplasm Proteins; Nucleosomes; Protein Processing, Post-Translational | 2013 |
The RNA-overmethylation in brain tumours. Data and hypothesis.
Topics: Animals; Brain Neoplasms; Cell Differentiation; Cytogenetics; Glioma; Humans; Methylation; Mutation; Ribosomes; RNA, Neoplasm; RNA, Transfer | 1969 |
115 other study(ies) available for isomethyleugenol and Glioma
Article | Year |
---|---|
The CBL-LSD1-CXCL8 axis regulates methionine metabolism in glioma.
Topics: Cell Line, Tumor; Glioma; Histone Demethylases; Humans; Methionine; Methylation; Tumor Microenvironment | 2022 |
Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.
Topics: Brain Neoplasms; Endodeoxyribonucleases; Glioma; Humans; Methylation; Prognosis; RNA, Messenger; Tumor Microenvironment | 2023 |
DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis.
Topics: Biomarkers, Tumor; Brain Neoplasms; Epigenesis, Genetic; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Methylation; Prognosis; Tumor Microenvironment | 2022 |
RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma.
Topics: Brain Neoplasms; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methylation; RNA; Tumor Microenvironment | 2022 |
CPEB2 m6A methylation regulates blood-tumor barrier permeability by regulating splicing factor SRSF5 stability.
Topics: Animals; Astrocytes; Brain Neoplasms; Endothelial Cells; Epigenesis, Genetic; Glioma; Humans; Methylation; Methyltransferases; Mice; MicroRNAs; Microvessels; Permeability; RNA Splicing Factors; RNA-Binding Proteins; Serine-Arginine Splicing Factors; Zonula Occludens-1 Protein | 2022 |
Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy.
Topics: Glioma; Humans; Immunotherapy; Methylation; Prognosis; T-Lymphocytes; Tumor Microenvironment | 2023 |
Methylation class oligosarcoma may encompass IDH-wildtype gliomas.
Topics: Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mutation | 2023 |
Identification and validation of RNA methylation-related alternative splicing gene signature for low-grade glioma to predict survival and immune landscapes.
Topics: Alternative Splicing; Glioma; Humans; Methylation; Nomograms; RNA; Tumor Microenvironment | 2023 |
Editorial for "Apparent Diffusion Coefficient as Imaging Biomarker for Identifying IDH Mutation, 1p19q Codeletion, and MGMT Promoter Methylation Status in Patients With Glioma".
Topics: Biomarkers; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mutation; Tumor Suppressor Proteins | 2023 |
Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG).
Topics: CD18 Antigens; Glioma; Humans; Integrins; Methylation; Prognosis; Reproducibility of Results | 2022 |
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.
Topics: Activin Receptors, Type I; Child; ErbB Receptors; Genes, Homeobox; Glioma; Histones; Humans; Methylation; Mutation | 2023 |
The FDX1 methylation regulatory mechanism in the malignant phenotype of glioma.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Ferredoxins; Glioma; Methylation; MicroRNAs; Phenotype | 2023 |
N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Topics: Algorithms; Carcinogenesis; Gene Expression; Glioma; Humans; Methylation; Tumor Microenvironment | 2023 |
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cohort Studies; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Male; Methylation; Prognosis; Prospective Studies; Tumor Suppressor Proteins | 2023 |
MUC17 mutations and methylation are associated with poor prognosis in adult-type diffuse glioma patients.
Topics: Adult; Brain Neoplasms; Glioblastoma; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mucins; Mutation; Prognosis; Retrospective Studies | 2023 |
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.
Topics: Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Prognosis; Tumor Suppressor Proteins | 2023 |
Integrative analyses reveal biological function and prognostic role of m7G methylation regulators in high-grade glioma.
Topics: Glioma; Humans; Inflammation; Methylation; Prognosis; Tumor Microenvironment | 2023 |
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.
Topics: Animals; Brain Neoplasms; Female; Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mice; Mutation; Oncolytic Virotherapy; Oncolytic Viruses | 2023 |
Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
Topics: Brain Neoplasms; Glioma; Humans; Methylation; Prognosis; rap GTP-Binding Proteins; RNA; Tumor Microenvironment | 2023 |
LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2'-O-methylation.
Topics: Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Glioma; Humans; Methylation; Neoplastic Stem Cells; Ribonucleoproteins, Small Nucleolar; RNA, Long Noncoding | 2023 |
Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.
Topics: Child; Enzyme Activation; Gene Silencing; Glioma; Histones; Humans; Lysine; Methylation; Polycomb Repressive Complex 2; Protein Subunits | 2019 |
Further Investigation About Copy Number Variations and Methylation of HADC3 in Glioma.
Topics: DNA Copy Number Variations; Glioma; Humans; Methylation; Prognosis; Transcriptome | 2019 |
m6A RNA Methylation Controls Proliferation of Human Glioma Cells by Influencing Cell Apoptosis.
Topics: Adenosine; Apoptosis; Brain Neoplasms; Cell Line; Cell Movement; Cell Proliferation; Glioma; Humans; Methylation; Methyltransferases | 2019 |
Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Topics: Adult; Area Under Curve; Brain; Brain Neoplasms; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylation; Middle Aged; Reproducibility of Results; Retrospective Studies; ROC Curve; Tumor Suppressor Proteins | 2019 |
DR5 related autophagy can promote apoptosis in gliomas after irradiation.
Topics: Apoptosis; Autophagy; Brain Neoplasms; Caspase 8; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Methylation; Receptors, TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic | 2020 |
Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Histones; Humans; Methylation; Polycomb Repressive Complex 2 | 2020 |
Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas.
Topics: Enhancer of Zeste Homolog 2 Protein; Gene Expression; Glioma; Histones; Humans; Methylation; Mutation, Missense; Prognosis; Retrospective Studies; Spinal Cord Neoplasms | 2020 |
Computational identification and characterization of glioma candidate biomarkers through multi-omics integrative profiling.
Topics: Biomarkers, Tumor; Brain Neoplasms; Computational Biology; Gene Expression; Glioma; Humans; Methylation; Protein Kinase C | 2020 |
A novel Cas9-targeted long-read assay for simultaneous detection of IDH1/2 mutations and clinically relevant MGMT methylation in fresh biopsies of diffuse glioma.
Topics: Adult; Aged; Alcohol Oxidoreductases; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Line, Tumor; CRISPR-Associated Protein 9; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioma; Humans; Isocitrate Dehydrogenase; Male; Methylation; Middle Aged; Pilot Projects; Sequence Analysis, RNA; Tumor Suppressor Proteins; Young Adult | 2020 |
MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma.
Topics: DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Methylation; Promoter Regions, Genetic; Tumor Suppressor Proteins | 2020 |
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
Topics: Chromatin; Gene Expression; Gene Expression Regulation; Glioma; HEK293 Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Mesenchymal Stem Cells; Methylation; Mutation; Neoplastic Processes; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Protein Processing, Post-Translational | 2020 |
Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
Topics: Brain Neoplasms; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Methylation; MicroRNAs; Prognosis; Temozolomide | 2021 |
H3K27M in Gliomas Causes a One-Step Decrease in H3K27 Methylation and Reduced Spreading within the Constraints of H3K36 Methylation.
Topics: Cell Line, Tumor; Chromatin; DNA Methylation; Epigenomics; Gene Expression; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Lysine; Methionine; Methylation; Mutation; Polycomb Repressive Complex 2; Protein Processing, Post-Translational | 2020 |
LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromosomal Proteins, Non-Histone; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Methylation; MicroRNAs; Phenotype; Promoter Regions, Genetic; Proteolysis; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; RNA, Long Noncoding; Signal Transduction; Survival Analysis; TOR Serine-Threonine Kinases; Ubiquitination | 2020 |
Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer.
Topics: Animals; Brain Neoplasms; Disease Models, Animal; Epigenesis, Genetic; Epigenomics; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Lysine; Methylation; Mice, Knockout; Proto-Oncogene Proteins c-myc; ras Proteins; Tumor Suppressor Protein p53 | 2020 |
Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells.
Topics: Astrocytes; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Chromatin Immunoprecipitation; Chromatin Immunoprecipitation Sequencing; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioma; High-Throughput Nucleotide Sequencing; Histone Code; Histones; Humans; Methylation; Mutation, Missense | 2020 |
Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O
Topics: Brain Neoplasms; DNA; Glioma; Humans; Isocitrate Dehydrogenase; Machine Learning; Magnetic Resonance Imaging; Methylation; Methyltransferases; Mutation; Retrospective Studies | 2021 |
Expression and prognostic characteristics of m
Topics: 5-Methylcytosine; Biomarkers, Tumor; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methylation; Neoplasm Grading; Prognosis; RNA; ROC Curve; Transcriptome | 2021 |
Noninvasive Assessment of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space-Occupancy Combined with Structural Magnetic Resonance Im
Topics: Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Magnetic Resonance Imaging; Methylation; O(6)-Methylguanine-DNA Methyltransferase; Retrospective Studies; World Health Organization | 2021 |
Upregulation of hsa-miR-196a-5p is associated with MIR196A2 methylation and affects the malignant biological behaviors of glioma.
Topics: Carcinogenesis; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methylation; MicroRNAs; Up-Regulation | 2021 |
Editorial for "Noninvasive Assessment of MGMT Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space Occupancy Combined with Structural MR Imaging".
Topics: Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Magnetic Resonance Imaging; Methylation; Promoter Regions, Genetic; Tumor Suppressor Proteins; World Health Organization | 2021 |
Identification and characterization of a novel mutant isocitrate dehydrogenase 1 inhibitor for glioma treatment.
Topics: Benzeneacetamides; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Stability; Glioma; Histones; Humans; Imidazoles; Isocitrate Dehydrogenase; Methylation; Models, Molecular; Molecular Targeted Therapy; Mutant Proteins; Mutation; Protein Binding | 2021 |
MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas.
Topics: Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; DNA Modification Methylases; DNA Repair Enzymes; Glioma; Humans; Infant; Isocitrate Dehydrogenase; Methylation; Mutation; Promoter Regions, Genetic; Tumor Suppressor Proteins | 2021 |
Identification of Critical m
Topics: Biomarkers, Tumor; Brain Neoplasms; Cluster Analysis; Computational Biology; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Male; Methylation; Middle Aged; Prognosis; Risk Factors; RNA; Transcriptome; Tumor Microenvironment | 2021 |
Expression, methylation and prognostic feature of EMILIN2 in Low-Grade-Glioma.
Topics: Adult; Aging; Biomarkers, Tumor; Brain Neoplasms; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; Humans; Kaplan-Meier Estimate; Male; Methylation; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Survival Analysis; Transcriptome | 2021 |
Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation.
Topics: Alcoholism; Auranofin; Cell Line, Tumor; Cell Proliferation; Child; Disulfiram; Down-Regulation; Drug Repositioning; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioma; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Myeloid-Lymphoid Leukemia Protein; Neoplasm Grading; Protein Processing, Post-Translational; Proteolysis; Transcription, Genetic | 2021 |
A Risk Signature Consisting of Eight m
Topics: Adenosine; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methylation; Protein Processing, Post-Translational; RNA-Binding Proteins | 2022 |
Epigenetic therapy with inhibitors of histone methylation suppresses DNA damage signaling and increases glioma cell radiosensitivity.
Topics: DNA Damage; Glioma; Histones; Humans; Methylation; Radiation-Sensitizing Agents; Signal Transduction | 2017 |
Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Female; Glioma; Histones; Humans; Magnetic Resonance Imaging; Male; Methylation; Middle Aged; Mutation; Neoplasm Staging; Prevalence; Retrospective Studies; Young Adult | 2017 |
IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation.
Topics: Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mutation; RNA | 2017 |
Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation.
Topics: Amino Acid Sequence; Asian People; Cell Cycle Proteins; DNA Replication; Ethnicity; Glioma; HeLa Cells; Histones; Humans; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Mutant Proteins; Phosphorylation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; S Phase; Survival Analysis | 2017 |
Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1.
Topics: Biocatalysis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioma; Histones; Humans; Lysine; Methylation; Neoplasm Invasiveness; Neoplasm Metastasis; Promoter Regions, Genetic; Retinoblastoma-Binding Protein 2; Zinc Finger E-box-Binding Homeobox 1 | 2018 |
Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.
Topics: Animals; Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; Brain Neoplasms; Cell Line, Tumor; Cell Survival; DNA Damage; DNA Repair; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Glioma; Histones; Humans; Lysine; Methylation; Mice, Nude; Temozolomide; X-linked Nuclear Protein; Xenograft Model Antitumor Assays | 2018 |
Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4.
Topics: Adult; Aged; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Male; Methylation; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Transcription Factors; Young Adult | 2018 |
In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Cerebral Blood Volume; Chromosome Deletion; Chromosomes, Human, 1-3; Contrast Media; Cross-Sectional Studies; DNA Modification Methylases; DNA Repair Enzymes; Gene Expression Profiling; Glioblastoma; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Angiography; Methylation; Middle Aged; Mutation; Retrospective Studies; Tumor Suppressor Proteins; X-linked Nuclear Protein; Young Adult | 2019 |
Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma?
Topics: Glioma; Humans; Isocitrate Dehydrogenase; Methylation; Mutation; Prognosis; Programmed Cell Death 1 Receptor | 2018 |
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M
Topics: Animals; Brain Neoplasms; Gangliosides; Glioma; Histones; Humans; Immunotherapy, Adoptive; Lysine; Methylation; Mice; Receptors, Antigen, T-Cell; Xenograft Model Antitumor Assays | 2018 |
Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability.
Topics: Brain Stem Neoplasms; Cell Line; Chromatin; DNA End-Joining Repair; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Fanconi Anemia Complementation Group D2 Protein; Fibroblasts; Genomic Instability; Glioma; HEK293 Cells; Histones; Humans; Methylation; Tumor Suppressor p53-Binding Protein 1 | 2018 |
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.
Topics: Brain Stem Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cellular Reprogramming; Enhancer Elements, Genetic; Epigenomics; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Methylation; Mutation; Neuroglia; Polycomb-Group Proteins; Promoter Regions, Genetic; WT1 Proteins | 2018 |
Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
Topics: Adult; Aged; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioma; Humans; Male; Methylation; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Promoter Regions, Genetic; Radiotherapy, Adjuvant; Reoperation; Retreatment; Retrospective Studies; Risk Factors; Tumor Suppressor Proteins | 2018 |
Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutSα interaction.
Topics: Carcinogenesis; Cell Line, Tumor; Child; DNA Mismatch Repair; Genomic Instability; Glioma; Glycine; HEK293 Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Mutation; MutS DNA Mismatch-Binding Protein; Protein Binding; Protein Processing, Post-Translational | 2018 |
HMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion.
Topics: Adaptor Proteins, Signal Transducing; Animals; Astrocytes; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; CpG Islands; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Ontology; Glioma; HMGB1 Protein; Integrin beta Chains; Methylation; Rats; RNA-Seq; Tumor Suppressor Proteins | 2019 |
Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma.
Topics: Animals; beta Catenin; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glioma; Glycogen Synthase Kinases; Histones; Humans; Methylation; Mice; Mice, Nude; MicroRNAs; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Prognosis; Proto-Oncogene Proteins c-akt; Signal Transduction; Transplantation, Heterologous | 2019 |
H3.3K27M-induced chromatin changes drive ectopic replication through misregulation of the JNK pathway in C. elegans.
Topics: Animals; Brain Neoplasms; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carcinogenesis; Cell Cycle; Chromatin; DNA Replication; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Germ Cells; Glioma; Heterochromatin; Histone Code; Histones; MAP Kinase Signaling System; Methylation; Polycomb Repressive Complex 2 | 2019 |
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas.
Topics: Adolescent; Adult; Age Factors; Brain Neoplasms; Case-Control Studies; Child; Cohort Studies; Exome; Glioma; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Infant; Methylation; Middle Aged; Mutation; Neoplasm Grading; Young Adult | 2013 |
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
Topics: Animals; Benzeneacetamides; Cell Differentiation; Cell Transformation, Neoplastic; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glutarates; Histones; Imidazoles; Isocitrate Dehydrogenase; Methylation; Mice; Mice, SCID; Mutant Proteins; Protein Multimerization; RNA Interference; Xenograft Model Antitumor Assays | 2013 |
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.
Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Genome, Human; Glioma; Histones; Humans; Methylation; Mutation; Tumor Cells, Cultured | 2013 |
High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK.
Topics: Age Factors; Aged; Brain Neoplasms; Glioma; Humans; Methylation; Molecular Diagnostic Techniques; Molecular Targeted Therapy; Neoplasm Grading; United Kingdom | 2013 |
PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Brain Neoplasms; DNA-Binding Proteins; Glioma; HEK293 Cells; HeLa Cells; Humans; Immunohistochemistry; Lysine; Methylation; Models, Biological; Phosphorylation; Protein Binding; Protein Phosphatase 2; Signal Transduction; Transcription Factor RelA; Transcription Factors; Tumor Necrosis Factor-alpha | 2013 |
TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.
Topics: Adult; Brain Neoplasms; Glioma; Humans; Methylation; Mutation; Promoter Regions, Genetic; Telomerase; Up-Regulation | 2013 |
Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
Topics: AC133 Antigen; Antigens, CD; Azepines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation; Neoplastic Stem Cells; Peptides; Promoter Regions, Genetic; Quinazolines; Signal Transduction; SOXB1 Transcription Factors; Transfection | 2014 |
Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling.
Topics: Amino Acid Substitution; Animals; Chromatin; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Gene Silencing; Glioma; Heterochromatin; Histone-Lysine N-Methyltransferase; Histones; Jumonji Domain-Containing Histone Demethylases; Lysine; Methionine; Methylation; Mutation; Signal Transduction | 2014 |
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
Topics: Animals; Apoptosis; Benzazepines; Brain Stem Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice; Pyrimidines; Xenograft Model Antitumor Assays | 2014 |
Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Electron Transport Complex I; Glioma; Humans; Male; Methylation; Mitochondria; Promoter Regions, Genetic; Rats, Sprague-Dawley; Tamoxifen; Temozolomide; Tumor Suppressor Proteins | 2015 |
[Aberrant expression of sox2 gene in malignant gliomas].
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioma; Histones; Humans; Methylation; Primary Cell Culture; Protein Processing, Post-Translational; SOXB1 Transcription Factors; Tumor Microenvironment | 2014 |
Methylation of the miR-126 gene associated with glioma progression.
Topics: Adult; Aged; Brain Neoplasms; Case-Control Studies; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genetic Association Studies; Glioma; Humans; Male; Methylation; MicroRNAs; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction | 2016 |
Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).
Topics: Amino Acid Substitution; Amino Acids; Amino Acids, Neutral; Animals; Biological Transport; Brain; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Hydrogen; Male; Methylation; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine | 2016 |
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis.
Topics: Astrocytes; Benzeneacetamides; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Glioma; Glutarates; Histones; Humans; Imidazoles; Isocitrate Dehydrogenase; Methylation; Mutation | 2016 |
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas.
Topics: Acetylation; Animals; Azepines; Brain Stem Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatin; Epigenomics; Gene Expression Regulation, Neoplastic; Glioma; Histone Code; Histones; Humans; Methylation; Mice; Molecular Targeted Therapy; Mutation; Neurogenesis; Nucleosomes; Polycomb Repressive Complex 2; Protein Transport; RNA-Binding Proteins; Triazoles; Xenograft Model Antitumor Assays | 2017 |
Exploring the substituent effects on a novel series of C1'-dimethyl-aryl Delta8-tetrahydrocannabinol analogs.
Topics: Cell Line; Cell Survival; Dronabinol; Glioma; Humans; Methylation; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2008 |
Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
Topics: Acetylation; Animals; Binding Sites; Brain; Brain Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylation; Female; Glioma; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Immunoglobulins; Membrane Proteins; Methylation; Mice; Mice, Nude; Neoplasm Transplantation; p300-CBP Transcription Factors; Promoter Regions, Genetic; RNA, Messenger; Sequence Analysis, DNA; Sp1 Transcription Factor | 2009 |
Redox dependence and compartmentation of [13C]pyruvate in the brain of deuterated rats bearing implanted C6 gliomas.
Topics: Animals; Astrocytes; Brain Chemistry; Brain Neoplasms; Carbon Isotopes; Cell Line, Tumor; Cerebral Cortex; Deuterium; Glioma; Glucose; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Methylation; Neoplasm Transplantation; Oxidation-Reduction; Pyruvic Acid; Rats; Rats, Wistar | 2009 |
Chk2 down-regulation by promoter hypermethylation in human bulk gliomas.
Topics: Brain; Cell Line, Tumor; Checkpoint Kinase 2; Chromatin Immunoprecipitation; DNA Damage; Down-Regulation; Genes, Reporter; Glioma; Humans; Luciferases, Firefly; Luciferases, Renilla; Methylation; Plasmids; Promoter Regions, Genetic; Protein Binding; Protein Serine-Threonine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Sp1 Transcription Factor; Transfection | 2010 |
Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.
Topics: Adolescent; Adult; Aged; Antigens, CD; Brain Neoplasms; Cadherins; Disease-Free Survival; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Ki-67 Antigen; Male; Methylation; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Young Adult | 2011 |
Aberrant hypermethylation of non-promoter zygote arrest 1 (ZAR1) in human brain tumors.
Topics: Astrocytoma; Brain; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Egg Proteins; Glioblastoma; Glioma; Humans; Mass Spectrometry; Melanoma; Methylation; Nevus; Oligodendroglioma; Pituitary Neoplasms; Reference Values | 2010 |
IDH mutation impairs histone demethylation and results in a block to cell differentiation.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Astrocytes; Cell Differentiation; Cell Line, Tumor; Cell Lineage; DNA Methylation; Enzyme Induction; Gene Expression Regulation; Glioma; Glutarates; HEK293 Cells; Histones; Humans; Isocitrate Dehydrogenase; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice; Mutation; Neural Stem Cells; Promoter Regions, Genetic | 2012 |
The role of protein arginine-methyltransferase 1 in gliomagenesis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Glioma; Histones; Humans; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA Interference; RNA, Small Interfering; Transplantation, Heterologous; Up-Regulation | 2012 |
Methylation mediated silencing of miR-23b expression and its role in glioma stem cells.
Topics: Antineoplastic Agents; Azacitidine; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Decitabine; Down-Regulation; Epigenesis, Genetic; Gene Silencing; Glioma; Humans; Methylation; MicroRNAs; Neoplastic Stem Cells; Promoter Regions, Genetic; Temozolomide | 2012 |
Distinct methylation profiles of glioma subtypes.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; CpG Islands; Female; Glioblastoma; Glioma; Humans; Infant; Male; Methylation; Middle Aged; Oligodendroglioma; Prognosis; Sulfites | 2003 |
Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.
Topics: Central Nervous System Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 9; Gene Deletion; Genes, p16; Glioma; Humans; Loss of Heterozygosity; Methylation; Microsatellite Repeats; Necrosis; Oligodendroglioma; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Promoter Regions, Genetic | 2003 |
Coordinate downregulation of a novel imprinted transcript ITUP1 with PEG3 in glioma cell lines.
Topics: Alleles; Animals; Base Sequence; Brain Neoplasms; Chromosomes, Human, Pair 19; Expressed Sequence Tags; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Kruppel-Like Transcription Factors; Methylation; Mice; Molecular Sequence Data; Polymorphism, Single Nucleotide; Protein Kinases; Transcription Factors; Tumor Cells, Cultured | 2004 |
Hypermethylation of the RASSF1A gene in gliomas.
Topics: Adolescent; Adult; Aged; Apoptosis Regulatory Proteins; Brain Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cyclin-Dependent Kinase Inhibitor p16; Death-Associated Protein Kinases; DNA, Complementary; Female; Gene Expression; Gene Frequency; Genes, Tumor Suppressor; Glioma; Humans; Male; Methylation; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sex Characteristics; Tumor Suppressor Proteins | 2004 |
Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
Topics: Animals; Blotting, Northern; Brain; Brain Neoplasms; Gene Expression Regulation, Neoplastic; Glial Fibrillary Acidic Protein; Glioma; Humans; Immunohistochemistry; Male; Methylation; Neoplasm Transplantation; Phosphopyruvate Hydratase; Protein D-Aspartate-L-Isoaspartate Methyltransferase; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2005 |
Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity.
Topics: Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Radiation; Glioma; Humans; Methylation; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Radiation Dosage; Radiation Tolerance; Radiation, Ionizing; Tumor Suppressor Proteins | 2006 |
Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.
Topics: Alternative Splicing; Amino Acid Sequence; Brain Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; DNA, Complementary; Down-Regulation; Exons; Gene Expression Regulation, Neoplastic; Glioma; GPI-Linked Proteins; Humans; Methylation; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm | 2007 |
Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene.
Topics: Base Sequence; Cell Line; DNA Restriction Enzymes; DNA, Neoplasm; Glioma; Humans; Lung Neoplasms; Melanoma; Methylation; Neoplasms; Oncogenes | 1984 |
Alteration in phospholipid methylation and impairment of signal transmission in persistently paramyxovirus-infected C6 rat glioma cells.
Topics: Adenylyl Cyclases; Animals; Cell Line; Enzyme Activation; Glioma; Membrane Lipids; Methylation; Phosphatidylethanolamines; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Respirovirus Infections | 1982 |
Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines.
Topics: Base Sequence; Chromatin; Deoxyribonuclease HpaII; Deoxyribonucleases, Type II Site-Specific; Gene Expression Regulation, Neoplastic; Glioma; Humans; Methylation; Methyltransferases; Models, Genetic; Molecular Sequence Data; Nervous System Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Protein Binding; Restriction Mapping; Sp1 Transcription Factor; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
Topics: 5-Methylcytosine; Alleles; Azacitidine; Base Sequence; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carrier Proteins; Chromosomes, Human, Pair 9; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Cytosine; Decitabine; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Methylation; Molecular Sequence Data; Neoplasm Proteins; Neoplasms; Sequence Deletion; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Contribution of O6-methylguanine-DNA methyltransferase to monofunctional alkylating-agent resistance in human brain tumor-derived cell lines.
Topics: Alkylating Agents; Antineoplastic Agents; Brain Neoplasms; Cell Adhesion; Colonic Neoplasms; Culture Media; Drug Resistance; Drug Screening Assays, Antitumor; Ethylnitrosourea; Glioma; Medulloblastoma; Methylation; Methylnitronitrosoguanidine; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Tumor Cells, Cultured | 1995 |
C-terminal CTII motif of 2',3'-cyclic nucleotide 3'-phosphodiesterase undergoes carboxylmethylation.
Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Alkylation; Amino Acid Sequence; Animals; Baculoviridae; Cell Line; Cell-Free System; Glioma; Methylation; Molecular Sequence Data; Myelin Sheath; Nerve Tissue Proteins; Oligodendroglia; Phosphoric Diester Hydrolases; Protein Prenylation; Protein Processing, Post-Translational; Protein Structure, Tertiary; Rats; Recombinant Fusion Proteins; Spodoptera; Tumor Cells, Cultured | 1994 |
Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells.
Topics: Base Sequence; Cell Nucleus; DNA Primers; Gene Expression Regulation, Enzymologic; Genes; Glioma; Humans; Introns; Methylation; Methyltransferases; Molecular Sequence Data; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Restriction Mapping; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Human blood group B-active ganglio-glycosphingolipid in rat glioma.
Topics: ABO Blood-Group System; Animals; Carbohydrate Sequence; Cell Line; Fatty Acids; Glioma; Glycoside Hydrolases; Glycosphingolipids; Humans; Magnetic Resonance Spectroscopy; Methylation; Molecular Sequence Data; Rats; Spectrometry, Mass, Fast Atom Bombardment | 1993 |
Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
Topics: Astrocytoma; Azacitidine; Base Sequence; Brain Chemistry; Brain Neoplasms; Carrier Proteins; Chromatin; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Methylation; Molecular Sequence Data; Neoplasm Proteins; Regulatory Sequences, Nucleic Acid; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1996 |
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Topics: Adult; Breast Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cell Line; Child; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 9; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Dinucleoside Phosphates; DNA; DNA, Neoplasm; Female; Genes, Tumor Suppressor; Glioma; Homozygote; Humans; Leukemia; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphocytes; Male; Methylation; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Reference Values; Restriction Mapping; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1996 |
Alteration of c-fos gene methylation in human gliomas.
Topics: Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cytosine; DNA, Neoplasm; Exons; Female; Genes, fos; Glioma; Humans; Introns; Male; Methylation; Middle Aged; RNA, Messenger; Tumor Cells, Cultured | 1996 |
Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene.
Topics: Base Sequence; Binding Sites; CpG Islands; Cytosine; DNA, Neoplasm; Gene Expression; Genetic Linkage; Glioma; Humans; Methylation; Methyltransferases; Molecular Sequence Data; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; X Chromosome | 1996 |
A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.
Topics: Adult; Aged; Brain Neoplasms; Carrier Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Neoplasm; Female; Gene Deletion; Genes, p53; Genes, Tumor Suppressor; Glioma; Humans; Male; Methylation; Middle Aged; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1996 |
Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.
Topics: Brain Neoplasms; Carrier Proteins; Cyclin-Dependent Kinase Inhibitor p16; Dinucleoside Phosphates; Down-Regulation; Glioma; Humans; Immunohistochemistry; Methylation | 1996 |
In vivo observation of lactate methyl proton magnetization transfer in rat C6 glioma.
Topics: Animals; Glioma; Lactates; Magnetic Resonance Spectroscopy; Male; Methylation; Models, Theoretical; Rats; Rats, Inbred F344 | 1999 |
Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene.
Topics: Animals; Base Sequence; Cell Line; Cell Nucleus; Enhancer Elements, Genetic; Gene Expression; Glioma; Humans; Interleukin-1; Interleukin-6; L Cells; Methylation; Mice; Molecular Sequence Data; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; RNA, Messenger; Sequence Homology, Nucleic Acid; Transcription, Genetic; Transfection | 1990 |
The effect of polar head group substitution on phospholipid methylation and the beta-adrenergic response in C6 glial cells.
Topics: Animals; Cell Line; Cell Membrane; Cyclic AMP; Glioma; Isoproterenol; Methylation; Methyltransferases; Phosphatidylethanolamine N-Methyltransferase; Phosphatidylethanolamines; Phospholipids; Rats | 1985 |
Cellular resistance to chloroethylnitrosoureas, nitrogen mustard, and cis-diamminedichloroplatinum(II) in human glial-derived cell lines.
Topics: Carmustine; Cell Line; Cell Survival; Cisplatin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Glioma; Humans; Mechlorethamine; Methylation; Nimustine; Nitrosourea Compounds; Sister Chromatid Exchange | 1987 |
Biochemical patterns in brain tumours. 3. Transfer ribonucleic acid.
Topics: Astrocytoma; Biological Transport; Brain Chemistry; Brain Neoplasms; Glioma; Humans; Medulloblastoma; Methylation; Nucleosides; RNA, Neoplasm; Spectrophotometry | 1969 |
Transfer and ribosomal ribonucleic acids in brain tumors.
Topics: Brain Neoplasms; Glioma; Humans; Methylation; Ribosomes; RNA, Neoplasm; RNA, Transfer | 1971 |